Mounjaro: type 2 diabetes drug more effective than Ozempic to launch in the UK — here’s what you need to know

By Duane Mellor, Lead for Evidence-Based Medicine and Nutrition, Aston Medical School, Aston University
Craig Russell, Lecturer, Aston University
Srikanth Bellary, Clinical Associate Professor, Diabetes and Endocrinology, Aston University

A new drug to treat type 2 diabetes has been approved for use) in the UK. Tirzepatide (sold under the brand name Mounjaro) could be available for prescription by early 2024 – subject to availability.

Mounjaro is an injectable treatment that helps the body to both control blood glucose (sugars) after meals and regulate appetite. Research into the drug has shown it’s more…

Read complete article

~	How collaboration from across Canada, and the world, is helping fight the Alberta wildfires

~	Video game performers are becoming Hollywood stars in their own right − and are on strike to be paid and protected accordingly

~	Paris Olympics: Canada’s soccer drone scandal highlights the need for ethics education

~	World News in Brief: Historic Palestine monastery on World Heritage in Danger List, rights office condemnation as Ghana upholds anti-gay law, free jailed Russian activist

~	Nearly half of children born in Wales in 2002-3 classed as having special educational needs – this may have negatively affected their attainment

~	Bosses are increasingly forcing workers back into the office – but evidence suggests it could backfire

~	Commonly used drug may extend women’s fertility, claim researchers – here’s what you need to know about rapamycin

~	The first farmers often made landscapes more biodiverse – our research could have lessons for rewilding today

~	An artist has stolen a coin from the British Museum as part of a performance piece – but is the artwork ethical?

~	Books That Shook the Business World: The Ecology of Commerce by Paul Hawken